KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityCurrent Deferred RevenueInterest DepositsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShares OutstandingShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ally Financial (ALLY) Cash & Equivalents (2016 - 2025)

Ally Financial's Cash & Equivalents history spans 16 years, with the latest figure at $107.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 0.94% year-over-year to $107.0 million; the TTM value through Dec 2025 reached $107.0 million, up 0.94%, while the annual FY2025 figure was $107.0 million, 0.94% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $107.0 million at Ally Financial, down from $373.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $15.8 billion in Q1 2021 and bottomed at $18.0 million in Q4 2022.
  • The 5-year median for Cash & Equivalents is $5.0 billion (2022), against an average of $5.4 billion.
  • The largest annual shift saw Cash & Equivalents tumbled 99.74% in 2021 before it skyrocketed 38483.33% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $40.0 million in 2021, then plummeted by 55.0% to $18.0 million in 2022, then surged by 38483.33% to $6.9 billion in 2023, then tumbled by 98.47% to $106.0 million in 2024, then rose by 0.94% to $107.0 million in 2025.
  • Per Business Quant, the three most recent readings for ALLY's Cash & Equivalents are $107.0 million (Q4 2025), $373.0 million (Q3 2025), and $106.0 million (Q4 2024).